The book discusses the recent progress in understanding the therapeutic targets for gallbladder cancer to provide opportunities for research and for developing innovative strategies that may enhance the benefit of conventional chemotherapy.
The book focuses on identifying candidate molecules and the overall status of the targeted therapies available for gallbladder cancer, as there is an urgent need to discover new molecular targets that can guide the emergence of new treatment strategies to improve patient outcomes and act as biomarkers for the early detection of diseases. Recently, new treatment therapeutics targets for gallbladder cancer patients have been identified and the field is evolving rapidly.
The book is relevant for the clinical researcher, surgeon, scientist and academician.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Dr. Vijay Kumar Shukla is Rector, Banaras Hindu University and Professor in the Department of General Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, UP, India. Dr. Shukla is internationally known for his research on gallbladder cancer and wound healing. He had been the visiting Professor at reputed international universities/medical schools. He has been honored with several national and international awards, including the Life Time Achievement Award at the World Union of Wound Healing Societies in Toronto, Canada, in 2008, for his exemplary work in wound healing and research. He was awarded the Fellow of the College of Wound Care Specialist (FCWCS), Malaysia, in 2017 and a fellowship of the National Academy of Medical Sciences in 2007.
In his illustrious career, Prof. Shukla has been the President of the Indian Society of Wound Management, Member of the ICMR task force on gallbladder cancer, Examiner and Inspector of the National Board of Examination, Vice-president, Hernia Society of India, Executive member, Association of Colon and Rectal Surgeons of India, Governing Council Member of ASI, Member, Independent Innovators Expert panel of Ministry of Health and Family Welfare, Govt. of India. He hosted the ASICON 2006 at Varanasi as Organizing Secretary. He has been a member of 12 national and international professional bodies and has published 470 papers in International and National Journals.
Dr. Manoj Pandey is a Professor in the Department of Surgical Oncology, Institute of Medical Sciences, Banaras Hindu University, Varanasi and Visiting Professor of the Department of Surgical Oncology, AIIMS, Rishikesh, Uttrakhand. He has served as the Director of Bhopal Memorial Hospital and Research Centre and National Institute for Research in Environmental Health, Indian Council of Medical Research. His research publications reflect his expertise in gallbladder cancer research and his aspiration for quality research. He has published more than 328 publications. He has been honored with several awards, including Dr. U C Gupta Memorial Award for Excellence in Surgery. Dr. Pandey has also been a member of the task force of ICMR on the review of cancer management.
Dr. Ruhi Dixit works as a Women Scientist in the Department of General Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India. She has a keen interest in cancer research and has been working on gallbladder cancer. She has published in various journals of international reputation. Moreover, she has served as a reviewer of a reputed double-blind referred international journal. To perform cutting-edge research, she has also participated in various hands-on trainings and workshops in related areas and has presented her novel findings on reputed international platforms. She is currently working on the development of diagnostic biomarkers for gallbladder cancer.
The book discusses the recent progress in understanding the therapeutic targets for gallbladder cancer to provide opportunities for research and for developing innovative strategies that may enhance the benefit of conventional chemotherapy.
The book focuses on identifying candidate molecules and the overall status of the targeted therapies available for gallbladder cancer, as there is an urgent need to discover new molecular targets that can guide the emergence of new treatment strategies to improve patient outcomes and act as biomarkers for the early detection of diseases. Recently, new treatment therapeutics targets for gallbladder cancer patients have been identified and the field is evolving rapidly.
The book is relevant for the clinical researcher, surgeon, scientist and academician.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
EUR 105,00 für den Versand von Deutschland nach USA
Versandziele, Kosten & DauerGratis für den Versand innerhalb von/der USA
Versandziele, Kosten & DauerAnbieter: Basi6 International, Irving, TX, USA
Zustand: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. Bestandsnummer des Verkäufers ABEJUNE24-291419
Anzahl: 2 verfügbar
Anbieter: ALLBOOKS1, Direk, SA, Australien
Brand new book. Fast ship. Please provide full street address as we are not able to ship toPOboxaddress. Bestandsnummer des Verkäufers SHUB291419
Anzahl: 1 verfügbar
Anbieter: Best Price, Torrance, CA, USA
Zustand: New. SUPER FAST SHIPPING. Bestandsnummer des Verkäufers 9789811964411
Anzahl: 2 verfügbar
Anbieter: Grand Eagle Retail, Mason, OH, USA
Hardcover. Zustand: new. Hardcover. The book discusses the recent progress in understanding the therapeutic targets for gallbladder cancer to provide opportunities for research and for developing innovative strategies that may enhance the benefit of conventional chemotherapy. The book focuses on identifying candidate molecules and the overall status of the targeted therapies available for gallbladder cancer, as there is an urgent need to discover new molecular targets that can guide the emergence of new treatment strategies to improve patient outcomes and act as biomarkers for the early detection of diseases. Recently, new treatment therapeutics targets for gallbladder cancer patients have been identified and the field is evolving rapidly. The book is relevant for the clinical researcher, surgeon, scientist and academician. The book discusses the recent progress in understanding the therapeutic targets for gallbladder cancer to provide opportunities for research and for developing innovative strategies that may enhance the benefit of conventional chemotherapy. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Bestandsnummer des Verkäufers 9789811964411
Anzahl: 1 verfügbar
Anbieter: Buchpark, Trebbin, Deutschland
Zustand: Hervorragend. Zustand: Hervorragend | Sprache: Englisch | Produktart: Bücher. Bestandsnummer des Verkäufers 40719817/1
Anzahl: 1 verfügbar
Anbieter: Buchpark, Trebbin, Deutschland
Zustand: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher. Bestandsnummer des Verkäufers 40719817/2
Anzahl: 1 verfügbar
Anbieter: moluna, Greven, Deutschland
Zustand: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Surgical Management, Adjuvant Chemotherapy and Palliative Chemotherapy in gallbladder cancerTargeted Therapies in gallbladder cancerClinical trials in gallbladder cancer treatmentDr. Vijay Kumar Shukla is Rector, Bana. Bestandsnummer des Verkäufers 673508802
Anzahl: Mehr als 20 verfügbar
Anbieter: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Deutschland
Buch. Zustand: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The book discusses the recent progress in understanding the therapeutic targets for gallbladder cancer to provide opportunities for research and for developing innovative strategies that may enhance the benefit of conventional chemotherapy. The book focuses on identifying candidate molecules and the overall status of the targeted therapies available for gallbladder cancer, as there is an urgent need to discover new molecular targets that can guide the emergence of new treatment strategies to improve patient outcomes and act as biomarkers for the early detection of diseases. Recently, new treatment therapeutics targets for gallbladder cancer patients have been identified and the field is evolving rapidly. The book is relevant for the clinical researcher, surgeon, scientist and academician. 368 pp. Englisch. Bestandsnummer des Verkäufers 9789811964411
Anzahl: 2 verfügbar
Anbieter: UK BOOKS STORE, London, LONDO, Vereinigtes Königreich
Zustand: Brand New. Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 7-10 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability. Bestandsnummer des Verkäufers CVS 9789811964411
Anzahl: 2 verfügbar
Anbieter: buchversandmimpf2000, Emtmannsberg, BAYE, Deutschland
Buch. Zustand: Neu. Neuware -The book discusses the recent progress in understanding the therapeutic targets for gallbladder cancer to provide opportunities for research and for developing innovative strategies that may enhance the benefit of conventional chemotherapy.The book focuses on identifying candidate molecules and the overall status of the targeted therapies available for gallbladder cancer, as there is an urgent need to discover new molecular targets that can guide the emergence of new treatment strategies to improve patient outcomes and act as biomarkers for the early detection of diseases. Recently, new treatment therapeutics targets for gallbladder cancer patients have been identified and the field is evolving rapidly.The book is relevant for the clinical researcher, surgeon, scientist and academician.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 368 pp. Englisch. Bestandsnummer des Verkäufers 9789811964411
Anzahl: 2 verfügbar